Tobacco and Nicotine Products Regulation and Policy Conference
October 28–29, 2025 | In-Person & Virtual Event
Overview
Join a diverse group of stakeholders—public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others—for this two-day conference on effectively regulating the broad spectrum of tobacco and nicotine products in the United States. Attendees will hear directly from FDA about the latest updates on regulations, guidance documents, and other initiatives. The conference will also include numerous discussions of timely tobacco and nicotine product issues and feature interactive dialogues between the panelists and audience.
New to Tobacco Regulation?
Start with FDLI’s Introduction to Tobacco and Nicotine Product Regulation course to gain a foundational understanding of the regulatory framework. This training is ideal preparation for the advanced content and discussions offered at this conference.
Call for Submissions
FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in June.
Sponsors
Gold
Sponsorship opportunities are available. Contact Cathy Scolieri for more information.
View 2025 Sponsorship Opportunities
Planning Committee
Tony Abboud, Vapor Technology Association
Jasjit Ahluwalia, Brown University
Shelly Blackwell, EAS Consulting Group
Michael Cummings, Medical University of South Carolina
Brittani Cushman, Turning Point Brands, Inc.
Cliff Douglas, Global Action to End Smoking
Joe G. Gitchell, Pinney Associates, Inc.
Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
Chris Howard, Swisher International, Inc.
Eshael Johnson, CTP-FDA
Eric N. Lindblom, O’Neill Institute for National and Global Health Law, Georgetown Law
John L. Marshall, Altria Client Services LLC
Daniel McGee, Buchanan Ingersoll & Rooney PC
Robin J. Mermelstein, University of Illinois-Chicago
Brian J. Miller, Johns Hopkins University
John O’Brien, RAI Services Company
Elizabeth Oestreich, ELIQUENT Life Sciences
Jason Robinson, JUUL Labs
Barry S. Schaevitz, Fox Rothschild LLP
Mark J. Vaders, Womble Bond Dickinson (US) LLP
LieAnn Van-Tull, Keller and Heckman LLP
Erin Warren, Philip Morris International
Jeffrey Weiss, Flagstaff Ventures
Jessica Zdinak, Applied Research and Analysis Company LLP
